Clicky

Yourgene Health Plc(YGEN)

Description: Yourgene Health PLC, formerly Premaitha Health PLC, is engaged in molecular diagnostics business for research into, and the development and commercialization of gene analysis techniques for pre-natal screening and other clinical applications in the early detection, monitoring and treatment of disease. The Company's product, the IONA test is a non-invasive in vitro diagnostic product for prenatal screening enabling clinical laboratories to offer a regulated non-invasive prenatal test in-house. The IONA test estimates the risk of a fetus having Down's syndrome or other serious genetic diseases. The risks that fetus may be affected with include Trisomy 21 (Down's syndrome), Trisomy 18 (Edwards' syndrome), Trisomy 13 (Patau's syndrome) and Fetal sex determination optional. The analysis is performed on cell-free placental deoxyribonucleic acid (DNA) from a maternal blood sample, with test results available in three days turnaround time.


Keywords: Medicine Disease Clinic Monitoring Genetics Molecular Diagnostics Medical Genetics Blood In Vitro Earl Genetic Diseases Laboratories Clinical Applications Midwifery Prenatal Testing Down Syndrome Down's Syndrome Gene Analysis

Home Page: www.yourgene-health.com

YGEN Technical Analysis

Skelton House
Manchester, M15 6SH
United Kingdom
Phone: 44 16 1669 8122


Officers

Name Title
Mr. Lyn Dafydd Rees CEO & Director
Mr. Barry Hextall CFO, Sec. & Exec. Director
Mr. Hayden William Jeffreys COO & Director
Dr. Joanne Mason Chief Scientific Officer & Director
Dr. Chia-Han Chang, Chan Ph.D. Chief Entrepreneur & Director
Ms. Zoe Crookes Legal Counsel
Ms. Joanne Cross Director of Marketing
Ms. Wendy Cox HR Director
Dr. Michael Risley Chief Devel. Officer
Dr. Matthew Forman Head of Bioinformatics & Software

Exchange: LSE

Country: UK

Currency: Pence sterling (p)

Forward PE: 77.5194
Trailing PE: 0
Price-to-Book MRQ: 0.4163
Price-to-Sales TTM: 0.3916
IPO Date:
Fiscal Year End: March
Full Time Employees: 253
Back to stocks